$17.5B
$476,000
0.01% of portfolio
6,205
Q4 2023
Added 3.24%
$157B
$464,000
0.01% of portfolio
5,072
Q1 2024
Reduced 1.4%
$502M
$556,000
0.01% of portfolio
42,800
Q4 2022
Reduced 0.28%
$25.6B
$365,000
0.01% of portfolio
3,500
Q3 2023
Reduced 0.14%
$684M
$774,000
0.01% of portfolio
17,900
Q4 2023
Reduced 32.71%
$1.19B
$429,000
0.01% of portfolio
14,700
Q4 2021
Reduced 21.39%
$132B
$285,000
0.01% of portfolio
1,119
Q1 2024
Reduced 5.09%
$64.1B
$688,000
0.01% of portfolio
610
Q1 2024
Reduced 38.07%
$175B
$377,000
0.01% of portfolio
1,030
Q1 2024
Added 5.97%
$68.7B
$610,000
0.01% of portfolio
3,300
Q1 2024
New
$4.73B
$719,000
0.01% of portfolio
5,885
Q4 2023
Added 12.63%
$109B
$318,000
0.01% of portfolio
776
Q1 2024
Added 16.52%
$72.5B
$590,000
0.01% of portfolio
2,199
Q1 2024
Reduced 0.14%
$21B
$651,000
0.01% of portfolio
7,372
Q1 2024
Reduced 2.64%
$11.6B
$349,000
0.01% of portfolio
2,775
Q1 2024
Reduced 0.18%
$19B
$578,000
0.01% of portfolio
11,125
Q1 2024
Added 3.49%
$37.8B
$759,000
0.01% of portfolio
18,086
Q1 2024
Added 7.18%
$28.4B
$751,000
0.01% of portfolio
1,200
Q1 2024
Added 100.0%
$110B
$601,000
0.01% of portfolio
3,119
Q1 2024
Added 1.36%
$844M
$746,000
0.01% of portfolio
68,710
Q1 2024
Added 41.06%
$1.45B
$303,000
0.01% of portfolio
14,055
Q1 2024
Reduced 3.3%
$20B
$217,000
0.0% of portfolio
6,050
Q1 2024
Reduced 5.47%
Royal Caribbean Cruises (Rcl)
-
$0
0.0% of portfolio
-
Q3 2023
New
Southwest Airlines CO (Luv)
-
$0
0.0% of portfolio
-
Q3 2023
Reduced 11.76%
Live Nation (Lyv) 9.4469 Conv
-
$0
0.0% of portfolio
-
Q4 2022
New
Apellis Pharmaceuticals Inc (A
-
$0
0.0% of portfolio
-
Q3 2020
New
Net Lease Office Properties
-
$0
0.0% of portfolio
-
Q1 2024
New
Stride Inc (Lrn) 18.9109 Con
-
$0
0.0% of portfolio
-
Q3 2021
New
$105B
$205,000
0.0% of portfolio
794
Q1 2024
New
$0
$0
0.0% of portfolio
550,491
Q1 2024
Reduced 0.47%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 3.38%
Guidewire Software Inc (Gwre)
-
$0
0.0% of portfolio
-
Q4 2021
Reduced 68.75%
Exact Sciences (Exas) 8.2076
-
$0
0.0% of portfolio
-
Q2 2020
Reduced 25.0%
Cerence Inc (Crnc) 26.7271 C
-
$0
0.0% of portfolio
-
Q3 2023
Reduced 40.83%
Biomarin Pharmaceutical (Bmrn)
-
$0
0.0% of portfolio
-
Q1 2024
Added 50.0%
Array Technologies Inc (Arry)
-
$0
0.0% of portfolio
-
Q1 2024
Added 100.0%
-
$0
0.0% of portfolio
-
Q1 2024
New
Lumentum Holdings (Lite) 10.
-
$0
0.0% of portfolio
-
Q4 2022
Reduced 40.0%
Patrick Industries Inc (Patk)
-
$0
0.0% of portfolio
-
Q4 2022
New
Greenbrier Cos Inc (Gbx) 18.
-
$0
0.0% of portfolio
-
Q2 2022
New
Ptc Therapeutics Inc (Ptct)
-
$0
0.0% of portfolio
-
Q2 2022
New
$106B
$205,000
0.0% of portfolio
1,000
Q1 2024
New
$10.4B
$202,000
0.0% of portfolio
1,250
Q2 2023
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 0.04%
-
$0
0.0% of portfolio
-
Q1 2024
New
$278M
$48,000
0.0% of portfolio
54,725
Q1 2024
Reduced 10.62%
$23.9B
$0
0.0% of portfolio
-
Q4 2023
Added 118.52%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 0.44%
-
$0
0.0% of portfolio
-
Q1 2024
Added 56.24%
-
$0
0.0% of portfolio
-
Q2 2023
New